Genomed

Genomed Debt

Debt of Genomed (GEN.WA) as of Nov 20, 2026.

Debt

0.00PLN

Last updated:

In 2022, Genomed's total debt was 0.00 PLN, a % change from the 0.00 PLN total debt recorded in the previous year.

The Genomed Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2015
47,700.00 PLN
Jan 1, 2016
26,100.00 PLN
Jan 1, 2017
48,300.00 PLN
Jan 1, 2018
170,700.00 PLN
Jan 1, 2019
103,600.00 PLN
Jan 1, 2020
843,000.00 PLN
Jan 1, 2021
0.00 PLN
Jan 1, 2022
0.00 PLN
The Genomed Debt history
YEARDebtYoY
0.00PLN—
0.00PLN-100.00%
843,000.00PLN+713.71%
103,600.00PLN-39.31%
170,700.00PLN+253.42%
48,300.00PLN+85.06%
26,100.00PLN-45.28%
47,700.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genomed Stock analysis

What does Genomed do? Genomed SA generates revenue through molecular diagnostics services based on DNA sequencing, particularly Next Generation Sequencing (NGS). The company offers gene mutation analysis for over 150 congenital diseases including infertility, cancer predisposition, cystic fibrosis, Alzheimer's disease, hearing loss, coeliac disease, cardiomyopathy, and obesity. Their primary clients are healthcare providers and research institutions seeking personalized medicine solutions and genomic technology integration. Genomed SA also provides DNA sequencing, analysis, and synthesis services for the biotechnological market, targeting academic and industrial research sectors. The company's business model focuses on developing advanced diagnostic tools for medical applications, with a strong emphasis on NGS technology. Their service portfolio includes specialized genetic testing for congenital conditions and research-oriented DNA services. By concentrating on personalized medicine and gene treatment clinics, Genomed SA positions itself as a provider of specialized genomic solutions for both clinical and research markets. Genomed SA's revenue streams are derived from diagnostic testing services for congenital diseases and biotechnological DNA services. The company serves healthcare facilities requiring genetic analysis for patient care and research organizations needing genomic data for scientific advancement. Their offerings target medical professionals and biotechnology companies seeking to implement genomic technology in their operations. Genomed is one of the most popular companies on Eulerpool.

Debt Details

Understanding Genomed's Debt Structure

Genomed's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Genomed's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Genomed’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Genomed’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Genomed stock

On Eulerpool you can find the complete historical development of Debt Genomed since 2006 – with annual values, charts, and detailed analysis.

Debt's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Genomed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genomed

All Key Metrics — Genomed